The Relationship Between Psychosocial Factors and Adherence to Treatment in Men, Premenopausal and Menopausal Women with Type 2 Diabetes Mellitus

Abstract

Introduction Type 2 Diabetes Mellitus (T2DM) is a chronic disease that begins in adulthood, and is caused by multiple factors. The onset of menopause involves changes that predispose women to the development of T2DM, which can worsen if the adherence to treatment is inadequate due to psychosocial factors or medications. The present study aims to describe the psychosocial factors that may affect adherence to treatment among men and premenopausal and menopausal women with T2DM. Methods This was a cross-sectional study of 96 patients with T2DM, who were divided into three groups: 1) men (n=32); 2) premenopausal women (n=32); and 3) menopausal women (n=32). Somatometric and metabolic control data were obtained. Adherence to treatment and psychosocial factors were evaluated: social support, belief in conventional medicine, disease denial, and depressive symptoms. Results Adherence to medication had a negative correlation with depressive symptoms in men (p <0.001) and menopausal women (p <0.021). Dietary adherence had a positive correlation with belief in conventional medicine in men (p <0.037) and premenopausal women (p <0.029). Conclusion Medication adherence in men and menopausal women was correlated with fewer depressive symptoms. Adherence to diet in men and premenopausal women was correlated with greater belief in conventional medicine. The results show the diversity of psychosocial factors among the groups that must be addressed in order to improve adherence.

Sex disparity of DAPT noncompliance in patients with left main stem PCI with DES

“…[10][11][12] Additionally, the influence of hormonal factors and psychosocial aspects unique to females could impact medication adherence. [13][14][15][16] The study also examined the impact of various patient characteristics on DAPT noncompliance. Comorbidities played a significant role, with diabetes and chronic kidney disease showing a positive association with noncompliance.…”

“…[10–12] Additionally, the influence of hormonal factors and psychosocial aspects unique to females could impact medication adherence. [13–16]…”

Resilience and Illness Denial as Predicting Factors for Adherent Behaviour

“…Which explains that patients with higher denial about their illness are not able to implement adherent behaviour to manage their health condition and improve their chronic illness outcome. But statistically significant correlation between resilience and adherent behaviour explains that patients with higher resilience can better implement adherent behaviour in their life which will contribute to better chronic illness outcome (Catalán, Crisóstomo, Santamaría, Sainz, Valverde, & Jaimes, 2022;Escobar Florez, Aquilera, De la Roca-Chiapas, Cervantes, & Garay-Sevilla, 2021;White et al, 2016).…”

Illness Denial in Medical Disorders: A Systematic Review

“…Health Attitudes and Behavior Several studies have been performed to evaluate attitudes of denial in patients with diabetes [76][77][78][79][80][81][82]. In particular, Hyphantis et al [77] showed that illness denial was a significant predictor of poor adherence (defined as delayed engagement to treatment) in outpatients with type 2 diabetes.…”